1st patient randomized in the international #OCTAVEtrial ! Comparing OCT-guided vs angiography-guided PCI in STEMI & NSTEMI. #OCTguidedPCI #OCTAVEtrial #Teamwork #Academicnetwork @EmilHolckMD @h_evald @DrPeterOKane @AshkanEftekhar1 @AUHCardio @AUHdk

During #TCT2025 in San Francisco, @mmamas1973 and @h_evald discuss the late-breaking NOBLE trial. Watch the full episode of Beyond the Data: https://t.co/2KG5VoGu49

The LMCA saga continued! 🔭In the OCTOBER trial, OCT guided PCI in true LM bifurcations was associated with a non-significant improvement in MACE - following the main trial. 🔥Even tough the LMCA ostium was difficult to visualize, USD in the edge was frequent! #TCT2025

Ten-year outcome in the NOBLE trial 🫀Today, we presented that there is no difference in all-cause mortality ten years after randomization to PCI or CABG in patients with unprotected LMCA disease. For more info contact @h_evald or me - always eager to interact!

Huge congratulations to @EmilHolckMD , my very good friend and colleague! So much effort, very well deserved! @AUHCardio @AUHdk @AarhusUn

This study points out where extra attention and care is essential in improving patient outcome. Proud of this analysis. @Octobertrial #BifurcationPCI #Imagingfirst https://t.co/MYr0cr2VBZ

Last Friday 🎓 MD., PhD. 🍾 Thanks to the assessment committee Per Lehnert, Joanna Wykrzykowska, Alf Inge Larsen. Thanks to @h_evald, @NielsRHolm , @omeedneghabat Now, looking forward to get important @OctoberTrial substudies published @AUHCardio, @AUHdk, @AarhusUni

Well deserved @EmilHolckMD !!

@GreggWStone @JHRo67 @sbrugaletta @PCRonline @SripalBangalore @Drroxmehran @DLBHATTMD @JACCJournals @escardio @shci_sec @secardiologia @TCTMD @mmamas1973 @NievesGonzalo1 @ColletCarlos @MaeharaAkiko Even 'expert' operators still have room for improvement! Pre-specified analysis of OCTOBER demonstrated unintended stent deformation in 10% (1 in 5 left main PCIs) & only 50% were detected by operators

We explore the latest data on OCT use in #cardiology with @NielsRHolm & @LNAndreasen “If [guideline committees] look at the totality of the data, I’m absolutely sure that they will come to the conclusion that intravascular imaging needs to be used in complex PCI” @OctoberTrial

5/ 📸 @LNAndreasen presented a new @OctoberTrial substudy on uintended stent deformation captured by #OCTfirst Slides: https://t.co/SoVjvF1AlO

In up to 20% of pts in whom coronary-artery revascularization is indicated, the lesion involves a branch point or bifurcation of the coronary artery. Whether PCI guided by OCT imaging could improve outcomes is unknown. OCTOBER trial Research Summary:

Read the full results of the OCTOBER trial, presented at #ESCCongress: Original Article: OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions https://t.co/Fzi2k0cc7a #cardiology #CardioTwitter

#ESCCongress @GreggWStone IC imaging meta-analysis Angio vs IVUS vs OCT 🔅Compared w angio-guided PCI, IVI w OCT or IVUS ⬇️ TLF by 31%, 🔅Driven by 46% ⬇️ cardiac☠️ IVI-guided PCI ⬇️ ST 52%-MI 18%-all-cause ☠️ 25%

Very proud of this publication. Thanks to @LNAndreasen @omeedneghabat @h_evald @DrPeterOKane @jcspratt @SimoneBiscaglia @BURZOTTA_F @odenstedt @ThueOlsen @AUHCardio @AUHdk @AarhusUni

If you are attending #ESCCongress dont miss @LNAndreasen presenting the @OctoberTrial ⬇️🤟

It´s tomorrow morning: Does OCT guiding improve clinical outcome after complex bifurcation PCI? @LNAndreasen @omeedneghabat @h_evald @DrPeterOKane @jcspratt @odenstedt @SimoneBiscaglia @BURZOTTA_F @DrKoltowski @StuartWatkins9 @jacockburn @ThueOlsen #ESCCongress #dcs_esc23

“Hot Line 4 is very important and will probably be the highlight of the Hot Lines for many cardiovascular health professionals. It includes a series of trials – ILUMIEN IV, OCTIVUS and OCTOBER..." @LNAndreasen @h_evald @omeedneghabat @jcspratt #cardotwitter #octfirst

Which method do you use to establish a coronary reference size? Major differences exist leading to concerning differences in stent diameter selection and evaluation of stent expansion

Well deserved 💥🙌